Ecron Acunova, a CRO based in Bangalore, India, has acquired a majority stake in aCROnordic, a CRO operating across the Nordic region, according to PharmaTimes.

Ecron has corporate offices Princeton, N.J., and in Frankfurt, Germany, and has operations in 19 Western and Eastern European countries as well as seven markets across South and South East Asia.

aCROnordic provides CRO services to the pharmaceutical and medical device industries, focusing on neurology, oncology and cardiology. Its headquarters are in Scion-DTU near Copenhagen, the largest university science park in Denmark, and its field of operations covers Denmark, Sweden, Finland and Norway.

D.A. Prasanna, founder and chairman of Ecron Acunova, said the recent shift toward strategic outsourcing in clinical research called for a “more global presence of preferred provider CROs.”

According to Søren Strøh, CEO of aCROnordic, the merger is “an opportunity to fulfill our dream of being the first Nordic development CRO in an international organization.”